What is Non-Hodgkin's (NHL) lymphoma in simple terms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Non-Hodgkin's Lymphoma Explained in Simple Terms

Non-Hodgkin's lymphoma (NHL) is a cancer that starts in your immune system cells called lymphocytes, causing them to grow abnormally and form tumors in your lymph nodes and other parts of your body. 1

What is Non-Hodgkin's Lymphoma?

  • NHL represents a diverse group of cancers that originate in the lymphatic system, specifically in B-lymphocytes (80-85% of cases), T-lymphocytes (15-20%), or rarely in natural killer (NK) cells 1
  • Unlike Hodgkin's lymphoma, NHL lacks the specific Reed-Sternberg cells that characterize Hodgkin's disease 2
  • NHL is one of the most common cancers in the United States, ranking as the 6th most frequent cancer diagnosis among men and women 1

Types of Non-Hodgkin's Lymphoma

NHL is divided into many different subtypes based on how the cells look under a microscope and their genetic features:

  • B-cell lymphomas (most common, 80-85% of cases) 1

    • Diffuse Large B-Cell Lymphoma (DLBCL) - about 31% of all NHL cases 1
    • Follicular Lymphoma (FL) - about 22% of all NHL cases 1
    • Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia (SLL/CLL) - about 6% 1
    • Mantle Cell Lymphoma (MCL) - about 6% 1
    • MALT Lymphoma - about 5% 1
  • T-cell lymphomas (less common, 15-20% of cases) 1

    • Peripheral T-cell Lymphoma (PTCL) - about 6% of all NHL cases 1
    • Other T-cell subtypes are less common 1

How NHL Affects Your Body

  • NHL typically starts in the lymph nodes but can begin in almost any part of the body 2
  • As abnormal lymphocytes accumulate, they form tumors, primarily in lymph nodes 2
  • These cancerous cells can spread through the lymphatic system to other lymph nodes or tissues 2, 3
  • In advanced stages, NHL can spread to organs outside the lymphatic system 2

Risk Factors

  • Age: NHL risk increases with age, with median age at diagnosis being over 60 years 4
  • Weakened immune system: People with HIV/AIDS or those taking immunosuppressive drugs 5
  • Autoimmune diseases: Conditions where the immune system attacks the body 3
  • Certain infections: Some viral infections may increase risk 3
  • In most cases, however, the exact cause remains unknown 3

Symptoms

  • Painless swelling of lymph nodes in neck, armpits, or groin 2
  • Unexplained fever, night sweats, and weight loss (called "B symptoms") 2
  • Fatigue and weakness 2
  • Symptoms may vary depending on where the cancer is located in the body 2

Diagnosis and Treatment

  • Diagnosis involves biopsy of affected tissue, typically a lymph node 2
  • Treatment depends on the specific type of NHL, its stage, and other factors 2, 6
  • Common treatments include:
    • Chemotherapy 2, 3
    • Immunotherapy (like rituximab) 3
    • Radiation therapy (especially for localized disease) 6
    • Stem cell transplantation (for aggressive or relapsed disease) 2, 3

Prognosis

  • Prognosis varies widely depending on the NHL subtype and stage 2
  • Some slow-growing (indolent) types may not require immediate treatment 2
  • Aggressive types often respond well to treatment and may be curable 2
  • The International Prognostic Index helps predict outcomes 2

NHL is a complex disease with many subtypes, but advances in treatment have significantly improved outcomes for many patients over the past decades 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Non-Hodgkin lymphoma: diagnosis and treatment.

Mayo Clinic proceedings, 2005

Research

Non-Hodgkin lymphoma: an update.

The Lancet. Oncology, 2004

Research

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988

Research

Non-Hodgkin's lymphoma.

Current problems in cancer, 1996

Research

[Non-hodgkin's lymphomas].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.